Richard Gless, Jr

Title: Richard Gless, Jr.: Innovator in Soluble Epoxide Hydrolase Inhibitors

Introduction

Richard Gless, Jr. is a notable inventor based in Hayward, CA (US). He has made significant contributions to the field of pharmacology, particularly in the development of inhibitors for soluble epoxide hydrolase (sEH). With a total of 3 patents, Gless has focused on creating innovative solutions for treating various diseases.

Latest Patents

Among his latest patents, Gless has developed conformationally restricted urea inhibitors of soluble epoxide hydrolase. These inhibitors incorporate multiple pharmacophores, making them useful in the treatment of diseases. His work in this area has the potential to advance therapeutic options for patients suffering from conditions related to sEH.

Career Highlights

Richard Gless, Jr. is affiliated with the University of California, where he continues to engage in research and development. His academic background and professional experience have positioned him as a key figure in his field. Gless's innovative approach to drug design has garnered attention and respect within the scientific community.

Collaborations

Some of his notable coworkers include Bruce D. Hammock and Paul Daniel Jones. Their collaborative efforts have contributed to the advancement of research in soluble epoxide hydrolase inhibitors.

Conclusion

Richard Gless, Jr. is a prominent inventor whose work in soluble epoxide hydrolase inhibitors showcases his commitment to advancing medical science. His contributions are paving the way for new treatments and improving patient outcomes.